Axentra Corp Limited has intimated BSE Limited about a scheduled meeting of the Board of Directors of the Company. The meeting is scheduled to be held on Thursday, November 05, 2026.
The primary agenda for the board meeting includes:
- Consideration and approval of the Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2026
- Consideration and approval of the Unaudited Consolidated Financial Results for the quarter and half year ended September 30, 2026
- Review and approval of the Limited Review Report accompanying the financial results
- Any other matter with the permission of the Chair
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirms that intimation regarding the closure of the Trading Window for dealing in the Shares of the Company has already been provided to the Stock Exchange.